Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 8-K
 
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934


Date of report (Date of earliest event reported):  March 4, 2011

Bacterin International Holdings, Inc.
(Exact Name of Registrant as Specified in Its Charter)
 
Delaware
(State or Other Jurisdiction of Incorporation)
 
001-34951
20-5313323
(Commission File Number)
(IRS Employer Identification No.)
 
600 Cruiser Lane Belgrade, Montana
59714
(Address of Principal Executive Offices)
(Zip Code)
 
(406) 388-0480
(Registrant’s Telephone Number, Including Area Code)
 
 
(Former Name or Former Address, if Changed Since Last Report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 
 
   
Item 3.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
 
    The Company’s common stock has been approved for listing on the NYSE Amex, and the Company expects that its common stock will begin trading on the NYSE Amex under the symbol “BONE” on or about March 7, 2011.  Until the Company’s common stock begins trading on the NYSE Amex, the Company’s common stock will continue to be quoted on the OTC Bulletin Board under the symbol BIHI.OB.
 
 
Item 7.01
Regulation FD Disclosure.
 
A copy of the press release announcing the matters described in Items 3.01 above is attached as Exhibit 99.1 and incorporated herein.  The information in this Item 7.01 and the document attached as Exhibit 99.1 are being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), nor otherwise subject to the liabilities of that section, nor incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 
Item 9.01.
Financial Statements and Exhibits.
 
(d)  Exhibits.
 
Exhibit No
  
Description
     
99.1
  
Press Release of Bacterin International Holdings, Inc., dated March 4, 2011 entitled “Bacterin International Holdings, Inc. Receives Approval for Listing on NYSE Amex”
 
 
 
 
 
SIGNATURE
 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Dated:  March 4, 2011   
     BACTERIN INTERNATIONAL HOLDINGS, INC.  
       
 
By:
/s/ Guy S. Cook  
    Name:  Guy S. Cook  
    Title:    President and Chief Executive Officer  
       
 
 
 
 

 
EXHIBIT INDEX
 
99.1
Press Release of Bacterin International Holdings, Inc., dated March 4, 2011 entitled “Bacterin International Holdings, Inc. Receives Approval for Listing on NYSE Amex”